Cargando…

Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2

Mostrar otras versiones (1)

Neutralization assays are experimental surrogates for the effectiveness of infection- or vaccine-elicited polyclonal antibodies and therapeutic monoclonal antibodies targeting SARS-CoV-2. However, the measured neutralization can depend on the details of the experimental assay. Here, we systematicall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farrell, Ariana Ghez, Dadonaite, Bernadeta, Greaney, Allison J., Eguia, Rachel, Loes, Andrea N., Franko, Nicholas M., Logue, Jennifer, Carreño, Juan Manuel, Abbad, Anass, Chu, Helen Y., Matreyek, Kenneth A., Bloom, Jesse D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504593/ https://www.ncbi.nlm.nih.gov/pubmed/36146867 http://dx.doi.org/10.3390/v14092061

Ejemplares similares

Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2
por: Farrell, Ariana Ghez, et al.
Publicado: (2022)

Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
por: Starr, Tyler N., et al.
Publicado: (2022)

The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
por: Greaney, Allison J., et al.
Publicado: (2021)

Influenza virus transcription and progeny production are poorly correlated in single cells
por: Bacsik, David J, et al.
Publicado: (2023)

Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
por: Starr, Tyler N., et al.
Publicado: (2022)

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
por: Greaney, Allison J., et al.
Publicado: (2022)

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
por: Greaney, Allison J., et al.
Publicado: (2022)

Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
por: Phelan, Thomas, et al.
Publicado: (2021)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice
por: Loes, Andrea N., et al.
Publicado: (2020)

Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice
por: Loes, Andrea N., et al.
Publicado: (2020)

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
por: Bertoglio, Federico, et al.
Publicado: (2021)

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021)

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning
por: Radford, Caelan E., et al.
Publicado: (2023)

Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning
por: Radford, Caelan E., et al.
Publicado: (2023)

In silico study of intrinsic dynamics of full-length apo-ACE2 and RBD-ACE2 complex
por: Liu, Qing, et al.
Publicado: (2021)

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
por: Starr, Tyler N., et al.
Publicado: (2022)

Jointly modeling deep mutational scans identifies shifted mutational effects among SARS-CoV-2 spike homologs
por: Haddox, Hugh K., et al.
Publicado: (2023)

Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody
por: Duan, Xuejun, et al.
Publicado: (2022)

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
por: Greaney, Allison J., et al.
Publicado: (2021)

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
por: Greaney, Allison J., et al.
Publicado: (2022)

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
por: Brown, Emily E. F., et al.
Publicado: (2021)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
por: Dadonaite, Bernadeta, et al.
Publicado: (2022)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor
por: Sinha, Siddharth, et al.
Publicado: (2021)

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
por: Bertoglio, Federico, et al.
Publicado: (2021)

hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants
por: Liu, Junli, et al.
Publicado: (2021)

Advanced Analysis of Biosensor Data for SARS-CoV-2 RBD and ACE2 Interactions
por: Forssén, Patrik, et al.
Publicado: (2020)

Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding
por: Yang, Li Jun, et al.
Publicado: (2021)

SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
por: Valério, Mariana, et al.
Publicado: (2022)

Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD
por: Kolesov, Denis E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n5b0jsrj9kj8j0jffgf9uut6sf